Helen Sabzevari
President & Chief Executive Officer Precigen
Dr. Helen Sabzevari is President and CEO of Precigen, a Maryland-based commercial-stage biopharmaceutical company, and member of the Precigen Board of Directors. She brings extensive expertise in research and development of immunotherapy-based therapeutics and experience translating novel treatments from pre-clinical stage into the clinic. Previously, she co-founded and served as Chief Scientific Officer of Compass Therapeutics and held leadership roles in Immuno-Oncology and Global Research and Early Development at Merck KGaA/EMD Serono. Dr. Sabzevari received her doctorate degree in cell and molecular immunology and completed her postdoctoral work at the Scripps Research Institute.
